Uncontrolled and Resistant Hypertension: From Guideline Updates to RAAS Mechanisms-Diagnosis and Management of Difficult to Control Hypertension

Video Transcription

Video Summary

The talk reviewed updated guidelines for diagnosing and managing difficult-to-control hypertension. Hypertension affects nearly half of U.S. adults, yet control rates remain poor and have worsened in recent years. Blood pressure categories were outlined: normal, elevated, stage 1, and stage 2 hypertension. Treatment is recommended for patients with confirmed BP above 140/90, or above 130/80 if they have cardiovascular disease or elevated ASCVD/PreventCBD risk, or if lifestyle changes fail. Stage 2 hypertension usually requires two medications, using first-line agents such as thiazides, ACE inhibitors/ARBs, and calcium channel blockers.  <br /><br />The lecture emphasized apparent resistant hypertension, which carries higher risks of stroke, heart failure, cardiac death, and kidney failure. Before labeling it true resistance, clinicians should rule out pseudo-resistance from nonadherence, white-coat effect, poor measurement technique, and suboptimal regimens. Secondary causes, especially primary aldosteronism and obstructive sleep apnea, should be evaluated. Screening, confirmatory testing, adrenal imaging, and adrenal venous sampling were discussed, with mineralocorticoid receptor antagonists recommended early when appropriate.

Meta Tag

Concept Primary Hypertension

Concept Blood Pressure Classification

Concept Antihypertensive Therapy

Concept Refractory Hypertension

Concept Stage 1 Hypertension

Keywords

resistant hypertension

blood pressure guidelines

stage 2 hypertension

primary aldosteronism

obstructive sleep apnea

Primary Hypertension

Blood Pressure Classification

Antihypertensive Therapy

Refractory Hypertension

Stage 1 Hypertension